9 were sells. Insider ownership decreased by a total of 419828 shares, which suggests that BSX's key executives are feeling less optimistic about the outlook for the stock. Finally, Jefferies Group LLC increased their price target on Boston Scientific from $26.00 to $28.00 and gave the company a "hold" rating in a report on Friday, April 7th. Krilogy Financial LLC lifted its position in shares of Boston Scientific by 5.9% during the 2nd quarter. Among active positions in the latest quarter, 239 holders increased their positions by a total of 51.95 million shares, 248 holders decreased the positions by a total of 44.32 million shares, and 107 holders held their positions. About 16.18M shares traded or 148.41% up from the average. Estabrook Cap has invested 0% in Boston Scientific Corporation (NYSE:BSX). It has outperformed by 33.83% the S&P500. This works out to a net increase in ownership of 7.64 million shares, and suggests that institutions are feeling bullish about the stock. The Jennison Associates Llc holds 1.19M shares with $110.97M value, up from 367,500 last quarter. Colgate Palmolive Co now has $64.14B valuation. The relative volume of the stock is 3.18. About 1.15M shares traded or 1.90% up from the average. Clovis Oncology, Inc. (NASDAQ:CLVS) has risen 282.71% since December 3, 2016 and is uptrending. It has underperformed by 10.47% the S&P500. Tarbox Family Office Inc has 308 shares. It also reduced Bristol Myers Squibb Co (NYSE:BMY) stake by 50,000 shares and now owns 50,000 shares. S&Co invested in 0.69% or 188,260 shares. Its up 0.58, from 1.07 in 2017Q1. Private Trust Na reported 47,878 shares. The company has a quick ratio of 0.50, a current ratio of 0.72 and a debt-to-equity ratio of 0.58. Beck Mack And Oliver Limited Com holds 0.02% or 24,600 shares in its portfolio. Victory Mgmt Incorporated holds 0% or 189 shares. Moreover, Redwood Invests Limited Liability has 1.24% invested in Boston Scientific Corporation (NYSE:BSX). Moreover, Cleararc Inc has 0.26% invested in Colgate-Palmolive Company (NYSE:CL). Oppenheimer & Company holds 14,124 shares. Dorsey Whitney Lc reported 5,642 shares. Mitsubishi Ufj &, a Japan-based fund reported 2.76 million shares. During the same quarter in the previous year, the firm earned $0.27 EPS. Trustco National Bank N Y holds 1.47% in Colgate-Palmolive Company (NYSE:CL) or 20,056 shares. State Treasurer State Of Michigan stated it has 0.01% in The New York Times Company (NYSE:NYT). 93,133 were reported by Oregon Employees Retirement Fund.
Since June 1, 2017, it had 0 insider buys, and 1 sale for $379,736 activity. On Wednesday, November 29 the stock rating was maintained by Canaccord Genuity with "Buy". Therefore 70% are positive. The stock has "Equal-Weight" rating by Barclays Capital on Wednesday, July 19. The company was maintained on Tuesday, October 31 by SunTrust. Wedbush has "Neutral" rating and $23 target. The shares price has positioned -9.68% down over the past quarter while it has directed -9.45% toward a falling position throughout past six months. Jefferies maintained the stock with "Buy" rating in Monday, August 28 report.
Aureus Asset Management LLC increased its holdings in shares of Boston Scientific Corporation (NYSE:BSX) by 0.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. Therefore 82% are positive. Boston Scientific now has a consensus rating of "Buy" and a consensus target price of $30.56.
Recent insider trends for Boston Scientific Corporation (NYSE:BSX) have caught the attention of investors. The firm has "Buy" rating by Bank of America given on Friday, January 27. Goldman Sachs Group Inc assumed coverage on Boston Scientific in a report on Tuesday, May 16th. Boston Scientific Corporation has been given an analysts' mean target of 31.32. Boston Scientific Corporation has a 1 year low of $20.36 and a 1 year high of $29.93.
Union Pacific Corporation (NYSE:UNP): Financial Health and Analyst Ratings
Kayne Anderson Rudnick Investment Mngmt Ltd Liability Corp holds 0.13% or 121,239 shares. 50,545 are held by Penn Incorporated. Currently, 1.72 million total shares are owned by the public and among those 1.67 million shares have been available to trade.
BSX has been the subject of several research reports. On Wednesday, December 21 the stock rating was maintained by WallachBeth Capital with "Hold". RBC Capital Markets maintained the shares of BSX in report on Monday, July 10 with "Buy" rating. Needham maintained Boston Scientific Corporation (NYSE:BSX) on Friday, November 3 with "Buy" rating.
Short interest is another tool that analysts use to gauge investor sentiment. To measure price-variation, we found BSX's volatility during a week at 4.93% and during a month it has been found around 2.41%. Winslow Evans And Crocker stated it has 1,000 shares or 0% of all its holdings. Board Of Trustees Of The Leland Stanford Junior University accumulated 3,780 shares. Rhumbline Advisers has 2.31M shares. Bluemountain Capital Management accumulated 0.02% or 30,060 shares.
Looking at the stock's movement on the chart, Viacom, Inc. have shares float of 7.74%. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since December 5, 2016 and is uptrending. It also reduced Cdk Global Inc (NASDAQ:CDK) stake by 59,189 shares and now owns 89,705 shares. Lilly Eli & Co (NYSE:LLY) was raised too. Its opening price on the last trading day was $26.15.